Winston & Strawn Advises on Cuprina’s $12MM IPO as Titan SPAC Raises $276MM
Winston & Strawn LLP is serving as underwriters counsel to R.F. Lafferty in connection with Cuprina Holdings, a biomedical and biotechnology company dedicated to the development and commercialization of products for chronic wound management and cosmeceuticals, in its announced closing...
Read moreDetails










